VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2020$4,385,000
+3.2%
1,506,7100.0%0.32%
-9.6%
Q1 2020$4,249,000
-16.1%
1,506,710
-3.4%
0.35%
+11.7%
Q4 2019$5,064,000–1,560,467–0.32%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders